Adcare Health Systems Inc RHEP
1.04
(0.02)
(1.89%)
as of 25 Sep
- Market cap
- $5.2M
- P/E
- 0.6×
Follow RHEP
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.67 | 1.08 | 2.56 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.05 | 0.07 | 0.07 | 0.15 | |
P/FCF ratio |
0.71 | 0.90 | 0.52 | 0.00 | |
P/Operating CF |
3.12 | (5.48) | (2.84) | (3.20) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.53 | 0.67 | 0.79 | 1.60 | |
EV/EBITDA |
9.63 | 11.74 | 10.79 | 54.80 | |
EV/Operating CF |
(16.78) | (13.27) | (18.63) | (1,482.24) | |
EV/FCF |
7.12 | 8.26 | 6.13 | (77.52) | |
Quick Ratio |
0.52 | 0.50 | 0.52 | 0.63 | |
Current Ratio |
0.65 | 0.64 | 0.67 | 1.35 | |
Net Debt/EBITDA |
70.00 | 1,082.57 | 9.84 | (1,537.45) | |
Debt/Assets |
62.62% | 63.35% | 63.64% | 67.33% | |
Debt/Equity |
14.29 | (44.30) | 8.56 | (31.59) | |
Asset Turnover |
1.27 | 1.06 | 0.83 | 0.58 | |
Operating CF/Net income |
(1.77) | 0.77 | (0.47) | (0.49) | |
Capex/Depreciation |
(0.65) | (0.49) | 11.79 | (0.50) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
27.40% | 30.81% | 17.66% | 24.53% | |
Intangible Assets out of Total Assets |
0.09 | 0.09 | 0.09 | 0.08 | |
Share Based Compensation of Revenue |
0.30% | 0.45% | 0.30% | 0.82% | |
Graham Net Nets |
(10.94) | (10.66) | (12.95) | (8.42) | |
Graham Number |
0.00 | 0.00 | 0.00 | 9.80 | |
Earnings Yield |
148.18% | 92.74% | 39.06% | (41.30%) | |
Free Cash Flow Yield |
140.18% | 111.53% | 191.26% | (13.63%) | |
Revenue per Share |
6.22 | 5.38 | 7.41 | 4.84 | |
Operating CF per Share |
0.35 | (0.23) | (0.45) | (0.58) | |
Capex per Share |
(0.13) | (0.09) | 3.48 | (0.09) | |
Free Cash Flow per Share |
0.23 | (0.32) | 3.03 | (0.67) | |
Cash per Share |
0.96 | 0.65 | 1.66 | 1.28 | |
Shareholders Equity per Share |
0.76 | (0.24) | 1.80 | (0.49) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.76 | (0.24) | 1.80 | (0.49) | |
Free Cash Flow |
0.89 | (1.25) | 8.50 | (2.08) | |
Working Capital |
(9.37) | (9.03) | (7.87) | 6.57 | |
Capital Expenditures |
(0.50) | (0.36) | 9.77 | (0.28) | |
Net Current Asset Value |
(47.26) | (52.02) | (46.48) | (48.41) | |
EV/EBIT |
27.42 | 35.11 | 25.30 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | (0.47) | 0.02 | |
Net Profit Margin |
(3.20%) | (5.47%) | 12.99% | 24.18% | |
Price to Operating Income |
2.75 | 3.81 | 2.16 | 0.00 | |
| Other line items | |||||
Average Receivables |
7.33 | 6.85 | 5.69 | 4.87 | |
Average Payables |
7.21 | 9.12 | 5.34 | 5.82 | |
Average Assets |
64.05 | 63.28 | 64.14 | 66.11 | |
Average Common Equity |
(20.36) | (19.35) | (18.20) | (19.47) |
Columns are period end dates